Heart Test Laboratories Inc. (NASDAQ:HSCS)’s traded shares stood at 1.65 million during the latest session, with the company’s beta value hitting 3.15. At the last check today, the stock’s price was $2.87, to imply an increase of 1.92% or $0.05 in intraday trading. The HSCS share’s 52-week high remains $85.18, putting it -2867.94% down since that peak but still an impressive 17.77% since price per share fell to its 52-week low of $2.36. The company has a valuation of $2.47M, with an average of 14940.0 shares in intraday trading volume over the past 10 days and average of 58.55K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Heart Test Laboratories Inc. (HSCS), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give HSCS a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -2.46.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Heart Test Laboratories Inc. (NASDAQ:HSCS) trade information
After registering a 1.92% upside in the latest session, Heart Test Laboratories Inc. (HSCS) has traded red over the past five days. The 5-day price performance for the stock is -10.74%, and -12.37% over 30 days. With these gigs, the year-to-date price performance is -83.19%. Short interest in Heart Test Laboratories Inc. (NASDAQ:HSCS) saw shorts transact 44987.0 shares and set a 1.29 days time to cover.
The extremes give us $3 and $3 for target low and target high price respectively. As such, HSCS has been trading -4.53% off suggested target high and -4.53% from its likely low.
Heart Test Laboratories Inc. (HSCS) estimates and forecasts
The rating firms project that company’s revenue will grow 8,584.20% compared to the previous financial year.
Revenue forecast for the current quarter as set by 2 analysts is 150k. Meanwhile, for the current quarter, a total of 2 analyst(s) estimate revenue growth to 350k.Earnings reports from the last fiscal year show that sales brought in nan and nan respectively in the corresponding quarters.
HSCS Dividends
Heart Test Laboratories Inc. has its next earnings report out on 2024-Jul-29. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
